Precision Diagnostics and Emerging Treatment Strategies
David M. Nanus, MD explores the advancements in diagnostic techniques and novel therapies in prostate cancer care.
Read MoreSelect Page
David M. Nanus, MD, is the Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine and the Director of Genitourinary Cancer at New York-Presbyterian Hospital – Weill Cornell Medicine Healthcare System Cancer Program. He is also Associate Director of Clinical Services at the Meyer Cancer Center at Weill Cornell.
Dr. Nanus completed his medical training at Albert Einstein College of Medicine in the Bronx. He then went on to complete a Fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center, and completed research training at the Sloan Kettering Institute in Manhattan. He was a physician-scientist at MSKCC and later joined the full-time faculty of Weill Cornell Medicine, where he serves as Chief of the Division of Hematology and Medical Oncology. He serves as PI in clinical, translational, and basic research in genitourinary malignancies and novel targeted therapies, and has 200+ publications. He has received numerous awards, including membership in the American Society for Clinical Investigation and the Association of American Physicians.
Posted by David M. Nanus, MD | May 2024
David M. Nanus, MD explores the advancements in diagnostic techniques and novel therapies in prostate cancer care.
Read MorePosted by David M. Nanus, MD | Jan 2020
David M. Nanus, MD, reviews the approvals for and evidence surrounding therapies to treat advanced prostate cancer. He focuses on taxane chemotherapy, androgen deprivation therapy, androgen receptor pathway inhibitors, bone-targeted therapy, and common approaches in tumor immunotherapy.
Read More